• Filing Date: 2020-11-03
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Intangible Asset (Narrative) (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2014
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]            
Amortization of intangible assets     $ 1,457,000 $ 1,451,000    
Net intangible assets $ 13,327,000   13,327,000     $ 14,783,000
Impairment     0      
License            
Finite-Lived Intangible Assets [Line Items]            
Gross intangible assets 25,000,000   $ 25,000,000      
Useful life (in years)     13 years      
Amortization of intangible assets 489,000 $ 489,000        
Net intangible assets $ 13,327,000 $ 14,783,000 $ 13,327,000 $ 14,783,000    
pSivida            
Finite-Lived Intangible Assets [Line Items]            
Milestone payment after the first product approved by the FDA         $ 25,000,000